Vaccine Delivery Device with Diffusion Barrier for Sustained Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine delivery methods fail to maintain high levels of antibodies for extended periods, requiring frequent revaccination and lacking a controlled release mechanism for antigen and adjuvants, especially for immunocontraception in animals.
Innovation Solution
A vaccine delivery device with a container having porous openings that restrict cells while allowing antibodies and antigens to pass through, featuring a vaccine depot and a diffusion barrier that prevents antibody-antigen complexes from passing, utilizing materials like polyvinylidene difluoride membranes and polyanhydride-based formulations to control antigen release based on antibody levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If traditional vaccine delivery methods are used, then vaccines can be administered to induce immune responses, but high antibody levels cannot be maintained for extended periods requiring frequent revaccination
Solution Approach 1:
The vaccine delivery device is implanted in advance to provide sustained release of antigen over time. The device contains antigen and adjuvant reservoirs that release materials continuously, eliminating the need for repeated vaccinations and maintaining protective antibody levels for extended periods (6-12 months or longer).
Solution Approach 2:
The device maintains continuous release of antigen and adjuvant through controlled diffusion and degradation mechanisms. The biodegradable polymer matrix gradually releases antigen while the adjuvant provides sustained immune stimulation, ensuring continuous antibody production without interruption or need for booster shots.
2Adaptability or versatility
If vaccine components are released continuously, then immune response is maintained, but antigen and adjuvant cannot be released in a controlled manner based on antibody levels
Solution Approach 1:
The device incorporates a feedback mechanism where released antigen acts as a stimulus that regulates further release. When antibody levels are low, more antigen is needed to stimulate the immune system, and the device responds by releasing additional antigen. When antibody levels are high, antigen release is reduced, preventing unnecessary immune stimulation and maintaining homeostasis.
Solution Approach 2:
The vaccine delivery device uses the immune system's own responses to regulate antigen release. The antigen itself serves as the control signal - its presence and concentration naturally regulate the release rate through immune complex formation and clearance mechanisms, eliminating the need for external control systems or complex sensors.
3Ease of manufacture
If a diffusion barrier is added to control antigen release, then antigen release can be regulated, but the device structure becomes more complex with multiple components
Solution Approach 1:
The diffusion barrier is integrated directly into the device structure as an inherent component rather than a separate add-on. The barrier layer is formed as part of the reservoir wall or matrix structure, combining the release control function with the structural framework. This merging reduces the number of discrete components while maintaining the controlled release capability.
Solution Approach 2:
The device utilizes porous biodegradable polymer materials that provide controlled diffusion pathways for antigen and adjuvant release. The porous structure inherently regulates release rates through diffusion control while maintaining mechanical integrity. The porosity can be tuned during manufacturing to achieve desired release profiles without adding complex active control mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device maintains high antibody levels for prolonged periods, eliminating the need for revaccination and providing sustained immunization and reproductive control in animals by controlled release of antigens, such as GnRH, ensuring long-term immunity and hormonal regulation.
Implementation Method 1
a diffusion barrier located within the container in a manner such that material (e.g., an antigenic vaccine component) within the vaccine depot must pass through the diffusion barrier before reaching one of the openings
Implementation Method 2
The barrier material allows free antibodies and free antigen to pass through the barrier material, and wherein the barrier material prevents antibody-antigen complexes from passing through the barrier material
Implementation Method 3
a container having a portion of its surface define porous openings that restrict intact cells from passing in and out of the container and that permit antibodies and vaccine antigens to pass in and out of the container
Data Source
AI summary
This document provides vaccine delivery devices and methods for vaccinating an animal (e.g., a mammal). For example, vaccine delivery devices that include a container having one or more openings, a vaccine depot located within the container, and a diffusion barrier located within the container in a manner such that material (e.g., an antigenic vaccine component) within the vaccine depot must pass through the diffusion barrier before reaching one of the openings are provided.